Relaxin and cardiovascular fibrosis

Chinese Pharmacological Bulletin

Volumn 23, Issue 9, 2007, Pages

  Wang, Ping ^a   Jia, San Qing ^a   Tang, Chao Shu ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cardiovascular; Fibrosis; Relaxin

Indexed keywords

MATRIX METALLOPROTEINASE; RELAXIN;

COLLAGEN SYNTHESIS; FIBROBLAST; HEART MUSCLE FIBROSIS; HUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 37049031245     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Dschietzig C, Richter C, Bartsch C, et al. The pregnancy hormone relaxin is a player in human heart failuxe[J]. FASEB J,2001,15 (12):2187-95.
2. Samuel C S, Unemori E N, Mookerjee I, et al. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo[J]. Endocrinology, 2004,145:4125- 33.
3. Lekgabe E D, Royce S G, Hewitson T D, et al. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs[J]. Endocrinology,2006,147(12): 5575-83.
4. Dschietzig T, Bartsch C, Kinkel T, et al. Myocardial relaxin counteracts hypertrophy in hypertensive rats[J]. Ann N Y Acad Sci, 2005,1041:441-3.
5. Fisher C, MacLean M, Morecroft I, et al. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?[J]. Circulation,2002, 16,106(3):292-5.
6. Perna A M, Masini E, Nistri S, et al. Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model[J]. FASEB J,2005,19(11):1525-7.
7. Lekgabe E D, Kiriazis H, Zhao C, et al. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats[J]. Hypertension, 2005,46(2):412-8.
8. Du X J, Samuel C S, Gao X M, et al. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype[J]. Cardiovasc Res,2003,57(2):395 -404.
9. Samuel C S, Zhao C, Bathgate R A, et al. The relaxin gene-knockout mouse: a model of progressive fibrosis[J]. Ann N Y Acad Sci, 2005,1041:173-81.
10. Zhang J, Qi Y F, Geng B, et al. Effect of relaxin on myocardial ischemia injury induced by isoproterenol[J]. Peptides,2005,26 (9):1632-9.
11. Mookerjee I, Unemori E N, DU X J, et al. Relaxin modulates fibroblast function, collagen production, and matrix metalloproteinase-2 expression by cardiac fibroblasts[J]. Ann N Y Acad Sci, 2005,1041:190-3.
12. Zhang W, Yang T, Su Y X, et al. Effects of Dipfluzine on the proliferation and collagen synthesis of cardiac fibroblasts and mechanisms[J]. Chin Pharmacol Bull,2006,22(2):207-12.
13. Conrad K P, Debrah D O, Novak J, et al. Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats[J]. Endocrinology,2004,145(7):3289-96.
14. Debrah D O, Conrad K P, Danielson L A, et al. Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response[J]. Ann N Y Acad Sci J Appl Physiol,2005, 98(3):1013-20.
15. Debrah D O, Conrad K P, Novak J, et al. Recombinant human relaxin (rhRLX) modifies systemic arterial properties in conscious rats irrespective of gender, but in a biphasic fashion[J]. Ann N Y Acad Sci,2005,1041:155-62.
16. Tozzi C A, Poiani G J, McHugh N A, et al. Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat[J]. Pulm Pharmacol Ther,2005,18(5):346-53.
17. Li Y, Brookes Z L, Kaufman S. Acute and chronic effects of relaxin on vasoactivity, myogenic reactivity and compliance of the rat mesenteric arterial and venous vasculature[J]. Regul Pept,2005, 132(1-3):41-6.
18. Jeyabalan A, Novak J, Doty K D, et al. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short term administration of relaxin [J]. Endocrinology,2007,148(1):189-97.
19. Jeyabalan A, Novak J, Danielson L A, et al. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries [J]. Circ Res,2003, 93(12):1249-57.
20. Debrah D O, Conrad K P, Jeyabalan A, et al. Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats[J]. Hypertension,2005,46(4):745-50.
21. Shpakov A O, Gur'ianov I A, Kuznetsova L A, et al. Study of molecular mechanisms of the relaxin action on adenylyl cyclase signaling system using synthetic peptides derived from the relaxin receptor LGR7[J]. Ross Fiziol Zh Im I M Sechenova,2006,92(5):521 -35.
22. Halls M L, Bathgate R A, Roche P J, et al. Signaling pathways of the LGR7 and LGR8 receptors determined by reporter genes[J]. Ann N Y Acad Sci,2005,1041:292-5.
23. Dschietzig T, Bartsch C, Richter C, et al. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB [J]. Circ Res,2003,92:32-40.